Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro M Machado

Showing results (21-30 of 227) with videos related to

Pageof 23
Sort By:
Joint Bone Spine|June 22, 2025
Treatment of idiopathic inflammatory myopathiesRaquel Campanilho-Marques, João Eurico Fonseca, Pedro M Machado
Current Opinion in Neurology|August 28, 2014
Sporadic inclusion body myositis: new insights and potential therapyPedro M Machado, Mazen M Dimachkie, Richard J Barohn
Journal of Neurology|November 18, 2022
Inclusion body myositis: from genetics to clinical trialsSara Nagy, Alaa Khan, Pedro M Machado, et al.
Rheumatology (Oxford, England)|November 6, 2024
Inclusion body myositis and immunosenescence: current evidence and future perspectivesNur Azizah Allameen, Sharfaraz Salam, Venkat Reddy, et al.
Clinical and Experimental Rheumatology|February 28, 2022
Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositisSharfaraz Salam, Mazen M Dimachkie, Michael G Hanna, et al.
Arthritis Care & Research|November 18, 2020
Long-Term Association Between Disease Activity and Disability in Early Axial Spondyloarthritis: Results From a Prospective Observational Study of Inflammatory Back PainPedro D Carvalho, Adeline Ruyssen-Witrand, Ana Marreiros, et al.
Clinical and Experimental Rheumatology|October 10, 2018
The role of imaging in evaluating patients with idiopathic inflammatory myopathiesKaterina Kubínová, R Dejthevaporn, Herman Mann, et al.
Current Opinion in Rheumatology|September 4, 2015
Genetic advances in sporadic inclusion body myositisQiang Gang, Conceição Bettencourt, Henry Houlden, et al.
Seminars in Arthritis and Rheumatism|September 17, 2022
Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studiesPedro David Carvalho, Elsa Vieira-Sousa, Ihsane Hmamouchi, et al.
Annals of the Rheumatic Diseases|September 8, 2020
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo <i>et al</i>Kimme L Hyrich, Milena Gianfrancesco, Pedro M Machado, et al.
Pageof 23

Showing results (21-30 of 227) with videos related to

Sort By:
Pageof 23
Joint Bone Spine|June 22, 2025
Treatment of idiopathic inflammatory myopathiesRaquel Campanilho-Marques, João Eurico Fonseca, Pedro M Machado
Current Opinion in Neurology|August 28, 2014
Sporadic inclusion body myositis: new insights and potential therapyPedro M Machado, Mazen M Dimachkie, Richard J Barohn
Journal of Neurology|November 18, 2022
Inclusion body myositis: from genetics to clinical trialsSara Nagy, Alaa Khan, Pedro M Machado, et al.
Rheumatology (Oxford, England)|November 6, 2024
Inclusion body myositis and immunosenescence: current evidence and future perspectivesNur Azizah Allameen, Sharfaraz Salam, Venkat Reddy, et al.
Clinical and Experimental Rheumatology|February 28, 2022
Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositisSharfaraz Salam, Mazen M Dimachkie, Michael G Hanna, et al.
Arthritis Care & Research|November 18, 2020
Long-Term Association Between Disease Activity and Disability in Early Axial Spondyloarthritis: Results From a Prospective Observational Study of Inflammatory Back PainPedro D Carvalho, Adeline Ruyssen-Witrand, Ana Marreiros, et al.
Clinical and Experimental Rheumatology|October 10, 2018
The role of imaging in evaluating patients with idiopathic inflammatory myopathiesKaterina Kubínová, R Dejthevaporn, Herman Mann, et al.
Current Opinion in Rheumatology|September 4, 2015
Genetic advances in sporadic inclusion body myositisQiang Gang, Conceição Bettencourt, Henry Houlden, et al.
Seminars in Arthritis and Rheumatism|September 17, 2022
Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studiesPedro David Carvalho, Elsa Vieira-Sousa, Ihsane Hmamouchi, et al.
Annals of the Rheumatic Diseases|September 8, 2020
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo <i>et al</i>Kimme L Hyrich, Milena Gianfrancesco, Pedro M Machado, et al.
Pageof 23